- Home
- What We Do
- Investment Banking
- Transactions
Transactions
Our corporate finance solutions are tailored to our clients’ strategic goals and delivered based on in depth expertise across a wide range of sectors globally. We have a strong track record, participating in 80 transactions and raising C$6.1 billion on behalf of our clients in Q1/231.2.
September 2022
Synoptek, Inc.
Financial Advisor to Synoptek on its Majority Investment from Quad-C Management
TECHNOLOGY
M&A ADVISORY
FINANCIAL SPONSORS
US
View transaction detail
September 2022
Searchspring
Financial Advisor to Searchspring on its Strategic Investment from PSG
TECHNOLOGY
M&A ADVISORY
FINANCIAL SPONSORS
US
View transaction detail
US$230m
September 2022
Akero Therapeutics, Inc.
Lead Manager (Follow-On)
HEALTHCARE
EQUITY CAPITAL MARKETS
US
View transaction detail
September 2022
Highwire
Financial Advisor to Highwire on its Strategic Investment from Shamrock Capital
TECHNOLOGY
M&A ADVISORY
FINANCIAL SPONSORS
US
View transaction detail
September 2022
Utility Cloud
Exclusive Financial Advisor (Sell side)
TECHNOLOGY
M&A ADVISORY
FINANCIAL SPONSORS
US
IRELAND
View transaction detail
September 2022
Dig Insights
Financial Advisor to Dig Insights on its Strategic Investment from Beringer Capital
TECHNOLOGY
M&A ADVISORY
FINANCIAL SPONSORS
CANADA
US
View transaction detail
August 2022
Kelso
Financial Advisor to Kelso on its Growth Investment in Emtec
TECHNOLOGY
FINANCIAL SPONSORS
M&A ADVISORY
US
View transaction detail
August 2022
RIA Advisory
Financial Advisor to RIA on its Strategic Investment from Avance Investment Management
TECHNOLOGY
M&A ADVISORY
US
View transaction detail
August 2022
WellSpring Consumer Healthcare
Financial Advisor (Sell side)
CONSUMER AND RETAIL
M&A ADVISORY
FINANCIAL SPONSORS
US
View transaction detail
August 2022
Planck Aerosystems, Inc.
Exclusive Financial Advisor (Sell side)
AEROSPACE & DEFENCE
INDUSTRIALS/AEROSPACE & DEFENSE
M&A ADVISORY
US
View transaction detail
August 2022
The Stable
Financial Advisor to The Stable on its Acquisition by Accenture
TECHNOLOGY
M&A ADVISORY
FINANCIAL SPONSORS
US
View transaction detail
US$10m
August 2022
Aytu BioPharma
Joint Bookrunner (Follow-On)
HEALTHCARE
EQUITY CAPITAL MARKETS
US
View transaction detail
- Company information as of June 30, 2022
- Transactions valued above C$1.5 million
* Transactions displayed here include transactions of Canaccord Genuity and its predecessors. The logos used in the tombstones represent Canaccord Genuity’s clients unless otherwise specified in the transaction description
How can we help?
If you would like to find out more about Canaccord Genuity or any of our services, please get in touch.